Zhou X - Search Results

1

Identification and targeting of selective vulnerability rendered by tamoxifen resistance.

Singh M, Zhou X, Chen X, Santos GS, Peuget S, Cheng Q, Rihani A, Arnér ESJ, Hartman J, Selivanova G. Singh M, et al. Among authors: zhou x. Breast Cancer Res. 2020 Jul 29;22(1):80. doi: 10.1186/s13058-020-01315-5. Breast Cancer Res. 2020. PMID: 32727562 Free PMC article.

2

Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity.

Zhou X, Singh M, Sanz Santos G, Guerlavais V, Carvajal LA, Aivado M, Zhan Y, Oliveira MMS, Westerberg LS, Annis DA, Johnsen JI, Selivanova G. Zhou X, et al. Cancer Discov. 2021 Dec 1;11(12):3090-3105. doi: 10.1158/2159-8290.CD-20-1741. Cancer Discov. 2021. PMID: 34230007 Free PMC article.

3

Decreased DNA Damage and Improved p53 Specificity of RITA Analogs.

Zhan Y, Zhou X, Peuget S, Singh M, Peyser BD, Fan Z, Selivanova G. Zhan Y, et al. Among authors: zhou x. Mol Cancer Ther. 2022 Oct 7;21(10):1524-1534. doi: 10.1158/1535-7163.MCT-22-0119. Mol Cancer Ther. 2022. PMID: 35877475 Free PMC article.

4

Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246.

Zhou X, Santos GS, Zhan Y, Oliveira MMS, Rezaei S, Singh M, Peuget S, Westerberg LS, Johnsen JI, Selivanova G. Zhou X, et al. Br J Cancer. 2022 Nov;127(11):2060-2071. doi: 10.1038/s41416-022-01971-8. Epub 2022 Sep 22. Br J Cancer. 2022. PMID: 36138076 Free PMC article.

5

Translating p53-based therapies for cancer into the clinic.

Peuget S, Zhou X, Selivanova G. Peuget S, et al. Among authors: zhou x. Nat Rev Cancer. 2024 Mar;24(3):192-215. doi: 10.1038/s41568-023-00658-3. Epub 2024 Jan 29. Nat Rev Cancer. 2024. PMID: 38287107 Review.

6

A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer.

Zhou XL, Werelius B, Lindblom A. Zhou XL, et al. Breast Cancer Res. 2004;6(3):R187-90. doi: 10.1186/bcr774. Epub 2004 Mar 9. Breast Cancer Res. 2004. PMID: 15084242 Free PMC article.

7

Definition of candidate low risk APC alleles in a Swedish population.

Zhou XL, Eriksson U, Werelius B, Kressner U, Sun XF, Lindblom A. Zhou XL, et al. Int J Cancer. 2004 Jul 1;110(4):550-7. doi: 10.1002/ijc.20173. Int J Cancer. 2004. PMID: 15122587

8

The estrogen receptor alpha C975G variant in familial and sporadic breast cancer: a case-control study.

Skoglund J, Margolin S, Zhou XL, Maguire P, Werelius B, Lindblom A. Skoglund J, et al. Anticancer Res. 2006 Jul-Aug;26(4B):3077-81. Anticancer Res. 2006. PMID: 16886637 Free article.

9

Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q.

Picelli S, Vandrovcova J, Jones S, Djureinovic T, Skoglund J, Zhou XL, Velculescu VE, Vogelstein B, Lindblom A. Picelli S, et al. BMC Cancer. 2008 Apr 1;8:87. doi: 10.1186/1471-2407-8-87. BMC Cancer. 2008. PMID: 18380902 Free PMC article.

10

Colorectal cancer as a complex disease: defining at-risk subjects in the general population - a preventive strategy.

Lindblom A, Zhou XL, Liu T, Liljegren A, Skoglund J, Djureinovic T; Swedish Low-Risk Colorectal Cancer Group. Lindblom A, et al. Expert Rev Anticancer Ther. 2004 Jun;4(3):377-85. doi: 10.1586/14737140.4.3.377. Expert Rev Anticancer Ther. 2004. PMID: 15161437 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,323 results

Search Page

Filters